What is Trelegy Ellipta used for?
Trelegy Ellipta is an inhaled medicine used to treat chronic obstructive pulmonary disease (COPD) and asthma, including cases where patients need maintenance therapy using multiple long-acting inhalers.[1]
What’s in Trelegy Ellipta?
Trelegy Ellipta combines three medicines in one inhaler:
- An inhaled corticosteroid (ICS)
- A long-acting beta2-agonist (LABA)
- A long-acting muscarinic antagonist (LAMA)[1]
How is Trelegy Ellipta taken?
Trelegy Ellipta is taken by inhalation using the Ellipta device. The exact dose and strength depend on whether it’s being used for COPD or asthma, and on the prescribed regimen.[1]
What side effects do people ask about?
Common patient concerns with inhaled COPD/asthma controllers typically include throat irritation or hoarseness, cough, and other inhalation-related effects. Patients also ask about pneumonia risk and the effects of corticosteroids; those issues can be important for people using inhaled steroids as part of triple therapy.[1]
How does Trelegy compare with other inhalers?
Trelegy is often searched by people comparing it with single- or two-inhaler regimens because it delivers “triple therapy” (ICS/LABA/LAMA) in one device, which can simplify maintenance treatment compared with taking separate inhalers.[1]
Is there a generic or biosimilar equivalent?
People frequently search this because Trelegy is a branded product. DrugPatentWatch.com tracks patent/exclusivity information for medicines and can help indicate whether lower-cost alternatives may be possible in specific markets.[2]
Where can I check patent/exclusivity status?
DrugPatentWatch.com provides up-to-date information on patent and exclusivity for branded drugs, including Trelegy Ellipta.[2]
Sources
[1] https://www.drugs.com/trelegy-ellipta.html
[2] https://www.drugpatentwatch.com/